Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Combination Chemotherapy in Treating Patients With Colon Cancer Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Combination Chemotherapy in Treating Patients With Colon Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Combination Chemotherapy in Treating Patients With Colon Cancer Clinical research trials and Combination Chemotherapy in Treating Patients With Colon Cancer healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Combination Chemotherapy in Treating Patients With Colon Cancer. Combination Chemotherapy in Treating Patients With Colon Cancer Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Combination Chemotherapy in Treating Patients With Colon Cancer clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Combination Chemotherapy in Treating Patients With Colon Cancer condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "C" Clinical Trials Conditions > Combination Chemotherapy in Treating Patients With Colon Cancer

Combination Chemotherapy in Treating Patients With Colon Cancer



Combination Chemotherapy in Treating Patients With Colon Cancer

For Condition: stage 2 colon cancer,stage 3 colon cancer,adenocarcinoma of the colon
Status: Recruiting
Sponsor(s): Groupe Regional d'Etudes du Cancer Colorectal ,
Synopsis: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which schedule of chemotherapy is most effective in treating colon cancer. PURPOSE: Randomizedphase III trial to compare different schedules of chemotherapy using carboplatin with fluorouracil and leucovorin in treating patients who have stage IIB or stage III colon cancer.
Details: OBJECTIVES: - Compare the disease-free survival of patients with completely resected stage IIB or III colon cancer treated with adjuvant chronomodulated vs standard schedule fluorouracil and leucovorin calcium with or without carboplatin. - Compare the overall survival of patients treated with these regimens. - Compare the toxicity of these regimens in these patients. - Compare the quality of life of patients treated with these regimens. - Determine the dose intensities of fluorouracil and carboplatin in these patients. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center and disease stage (IIB vs III). Patients are randomized to 1 of 4 treatment arms. - Arm I (standard schedule): Patients receive fluorouracil (5-FU) IV continuously and leucovorin calcium (CF) IV on days 1 and 2. - Arm II (standard + carboplatin schedule): Patients receive 5-FU and CF as in arm I plus carboplatin IV on day 1. - Arm III (chronomodulated schedule): Patients receive 5-FU IV continuously and CF IV continuously on days 1-4. - Arm IV (chronomodulated + carboplatin schedule): Patients receive 5-FU and CF as in arm III plus carboplatin IV continuously on days 1-4. Quality of life is assessed. Treatment in all arms repeats every 14 days for up to 9 courses in the absence of disease progression or unacceptable toxicity. PROJECTED ACCRUAL: A total of 660-800 patients will be accrued for this study.
Eligibility:
Study Type:  Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed adenocarcinoma of the colon - Stage IIB or III (Dukes stage B2 or C) - Complete curative resection performed within the past 7 weeks (negative margins) - No local or regional relapsed disease - Tumor more than 15 cm above the anal margin - Carcinoembryonic antigen less than 5 ng/mL (after surgery) - No rectal cancer - No metastatic disease PATIENT CHARACTERISTICS: Age - 18 and over Performance status - ECOG 0-1 OR - Karnofsky 60-100% Life expectancy - Not specified Hematopoietic - Neutrophil count at least 2,000/mm3 - Platelet count at least 100,000/mm3 Hepatic - Bilirubin no greater than 1.5 times upper limit of normal (ULN) - SGOT and SGPT no greater than 5 times ULN Renal - Creatinine no greater than 1.5 times ULN Cardiovascular - No serious coronary disease Other - Not pregnant - Fertile patients must use effective contraception - No concurrent infectious disease - No other malignancy except adequately treated basal cell skin cancer or carcinoma in situ of the cervix PRIOR CONCURRENT THERAPY: Biologic therapy - No prior immunotherapy Chemotherapy - No prior chemotherapy Endocrine therapy - Not specified Radiotherapy - No prior radiotherapy (before or after surgery) Surgery - See Disease Characteristics Other - No concurrent participation in another clinical trial
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
ChristianFocan,  Study Chair,  C.H.C - ASBL

Centre Hospitalier Hutois *Recruiting*
Huy,  ,  4500
Belgium
Recruiting Jean  Bury 085-272-005

C.H.C - Asbl *Recruiting*
LIEGE,  ,  B 4000
Belgium
Recruiting Christian  Focan 32-4-224-8990


Additional Information:
Study ID Numbers:  CDR0000257228;  EU-20201,GRECCR-03
Study Start Date: 
Record last reviewed: October 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046995

Other Adenocarcinoma Of The Colon Studies:
1. Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That has Been Removed During Surgery

2. Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

3. Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

4. Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer

5. Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer

Related Studies:

Other adenocarcinoma of the colon Clinical Trials
Other Clinical Trials
Other LIEGE Clinical Trials

Combination Chemotherapy in Treating Patients With Colon Cancer
Modify your Search

  Other adenocarcinoma of the colon Clinical Trials
  Other Clinical Trials
  Other LIEGE Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103